Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 1994. Start Trial.
Date Value
November 20, 2026 440.08
November 19, 2026 442.76
November 18, 2026 451.21
November 17, 2026 460.07
November 16, 2026 464.49
November 13, 2026 465.58
November 12, 2026 465.40
November 11, 2026 468.18
November 10, 2026 471.41
November 09, 2026 478.05
November 06, 2026 470.57
November 05, 2026 471.63
November 04, 2026 477.09
November 03, 2026 464.14
November 02, 2026 470.95
October 30, 2026 471.13
October 29, 2026 440.21
October 28, 2026 427.87
October 27, 2026 429.30
October 26, 2026 434.30
October 23, 2026 432.86
October 22, 2026 435.59
October 21, 2026 425.19
October 20, 2026 426.12
October 19, 2026 413.83
Date Value
October 16, 2026 417.52
October 15, 2026 420.72
October 14, 2026 408.99
October 13, 2026 393.31
October 12, 2026 399.65
October 09, 2026 401.84
October 08, 2026 400.78
October 07, 2026 404.16
October 06, 2026 400.35
October 05, 2026 395.10
October 02, 2026 396.04
October 01, 2026 398.06
September 30, 2026 407.57
September 29, 2026 414.49
September 28, 2026 419.38
September 25, 2026 420.47
September 24, 2026 415.37
September 23, 2026 412.27
September 22, 2026 424.99
September 21, 2026 424.31
September 18, 2026 419.21
September 17, 2026 419.36
September 16, 2026 411.16
September 15, 2026 408.53
September 14, 2026 413.40

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
GSK Plc 183.76
Johnson & Johnson 645.40
Eli Lilly & Co. 3563.61
Merck & Co., Inc. 413.52
Novo Nordisk A/S 67.68